Diazoxide labels and packages: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Diazoxide}} {{CMG}}; {{AE}} {{SS}} ==Labels and Packages== {| |thumb|800px |} {| |thumb|800px |} <ref name="da..." |
No edit summary |
||
| Line 5: | Line 5: | ||
==Labels and Packages== | ==Labels and Packages== | ||
{| | {| | ||
|[[File: | |[[File:Amiloride02.jpg|thumb|800px]] | ||
|} | |} | ||
{| | {| | ||
|[[File: | |[[File:Amiloride03—.jpg|thumb|800px]] | ||
|} | |} | ||
Revision as of 22:32, 26 February 2014
| Diazoxide |
|---|
| PROGLYCEM® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings and Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Diazoxide |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]
Labels and Packages
 |
References
- ↑ "PROGLYCEM (DIAZOXIDE) SUSPENSION [TEVA GLOBAL RESPIRATORY RESEARCH LLC]". Retrieved 26 February 2014.
Template:Nonsympatholytic vasodilatory antihypertensives Template:Other therapeutic products Template:Channel openers